688468.SH
科美诊断
SSE · Healthcare · Medical - Specialties · CN
CNY 6.25
−0.64%Year over year
Reported trailing growth
- Revenue
- -20.1%
- EBITDA
- —
- EBIT
- -57.2%
- EPS
- -65.0%
- Free cash flow
- +3.0%
- Operating cash flow
- -29.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -10.6%
- EBITDA
- -21.9%
- EBIT
- -33.7%
- Net income
- -34.0%
- EPS
- -33.8%
- Free cash flow
- -41.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026